|
|
|
Graduate in Medicine (Universidad Complutense de Madrid, 2000). PhD in Neuropatholoy (Universidad Complutense de Madrid). Juan Manuel Sepúlveda Sánchez is Attending Physician at the Neurooncology Unit in Hospital Universitario 12 de Octubre, Madrid, and the Vice-President of the Spanish Group for Research in Neurooncology (GEINO). |
Publications
-
Geometrical measures obtained from pretreatment postcontrast T1 weighted MRIs predict survival benefits from bevacizumab in glioblastoma patients
PLoS One 11(8) e0161484 (2016).
D. Molina, J. Pérez-Beteta, A. Martínez-González, J.M. Sepúlveda, S. Peralta, M. Gil-Gil, G. Reynes, A. Herrero, R. De Las Peñas, R. Luque, J. Capellades, C. Balaña, V.M. Pérez-Garcia
Projects
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024)
Sepúlveda, Juan M.
|
Graduate in Medicine (Universidad Complutense de Madrid, 2000). PhD in Neuropatholoy (Universidad Complutense de Madrid). Juan Manuel Sepúlveda Sánchez is Attending Physician at the Neurooncology Unit in Hospital Universitario 12 de Octubre, Madrid, and the Vice-President of the Spanish Group for Research in Neurooncology (GEINO). |
Publications
- Geometrical measures obtained from pretreatment postcontrast T1 weighted MRIs predict survival benefits from bevacizumab in glioblastoma patients
PLoS One 11(8) e0161484 (2016).
D. Molina, J. Pérez-Beteta, A. Martínez-González, J.M. Sepúlveda, S. Peralta, M. Gil-Gil, G. Reynes, A. Herrero, R. De Las Peñas, R. Luque, J. Capellades, C. Balaña, V.M. Pérez-Garcia
Projects
- Mathematical models for the digital transition in neuro-oncology: In-silico design of a clinical trial for glioblastoma.
Ministerio de Ciencia e Innovación (NextGenerationEU) (2023 - 2024)
